Pedunculopontine Nucleus Transcranial Ultrasound Stimulation for Freezing of Gait in Parkinson's
Official title: Pedunculopontine Nucleus Transcranial Ultrasound Stimulation as a Treatment of Freezing of Gait in Parkinson's Disease
Run by University Health Network, Toronto · NCT07695233 · Data updated 2026-11-12
This study tests whether targeted ultrasound stimulation of the Pedunculopontine nucleus can reduce freezing of gait in people with Parkinson’s disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | May 17, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07695233 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-90 with a confirmed Parkinson’s disease diagnosis and freezing of gait, on stable dopaminergic therapy for at least 4 weeks.
✕Probably not a fit
Individuals with significant cognitive impairment, implanted devices, or contraindications to MRI or TUS may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study will apply transcranial ultrasound stimulation to the Pedunculopontine nucleus in adults with Parkinson’s disease and freezing of gait. It uses a randomized, cross-over design to compare excitatory, inhibitory, and sham stimulation, with gait analyses and patient-reported outcomes to assess safety, tolerability, and impact on freezing of gait. Imaging, including rsfMRI and ASL, will examine brain connectivity and perfusion changes, and structural MRI will guide individualized stimulation parameters. The study enrolls 25 PD patients with FOG and 25 matched healthy controls to characterize effects and mechanisms. Primary outcomes focus on gait metrics and quality of life, while secondary analyses explore functional connectivity and safety signals via MRI.
Why it matters
Potential benefit: If successful, patients may experience reduced freezing episodes and improved mobility and quality of life.
How similar studies have gone: Previous work in neuromodulation and targeted brain stimulation for gait has shown promise, but this exact PPN-TUS approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-90 years of age * Confirmed diagnosis of a movement disorder with Freezing of Gait * Stable dopaminergic medication dose for a minimum of 4 weeks Exclusion Criteria: * History of stroke or seizure * Comorbid dementia * Scored below 22 on the Montreal Cognitive Assessment (MoCA) * Has intracranial implant(s) or device(s) * Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD) * Has a previous surgical intervention to treat the movement disorder such as lesioning or a DBS system in place. * Presence of metal implanted in body that is contraindicated in TMS/MRI * Pregnancy * Major depression/psychiatric disorder that in the opinion of the Investigator will affect patient's understanding of study procedures and willingness to abide by all procedures during the course of the study * Is on antipsychotics, marijuana, or other recreational drugs that affect the nervous system * Major musculoskeletal or neuromuscular disease or disorder of the hands, wrists and limbs * Major systemic illness or infection
Where it's running
-
Toronto Western Hospital
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Robert Chen, MD — University Health Network, Toronto
- Study coordinator: Julian Kwok
- Email: julian.kwok@uhn.ca
- Phone: 416-603-5800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Turning-focused versus strength exercise to reduce freezing of gait in Parkinson's disease
This study tests whether a turning-focused agility program or a strength-based exercise program helps people with Parkinson's who have freezing of gait reduce freezing episodes and improve everyday mobility.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.